BeiGene launches IPO on Shanghai’s STAR market to raise $3B
BeiGene Ltd announces the third round of its initial public offering (IPO) on the STAR market of Shanghai Stock Exchange to raise US $3.5 billion. The global biotech company, based in Beijing, China offers around 115 million ordinary shares, representing 8.62% of its total outstanding shares.
GO Prime with only $1.49 now